Vycor Medical (VYCO) Common Equity (2022 - 2023)
Vycor Medical (VYCO) has disclosed Common Equity for 6 consecutive years, with -$3.2 million as the latest value for Q3 2023.
- Quarterly Common Equity fell 14.65% to -$3.2 million in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$3.2 million through Sep 2023, down 14.65% year-over-year, with the annual reading at -$2.9 million for FY2022, N/A changed from the prior year.
- Common Equity for Q3 2023 was -$3.2 million at Vycor Medical, down from -$3.0 million in the prior quarter.
- The five-year high for Common Equity was -$2.6 million in Q1 2022, with the low at -$3.2 million in Q3 2023.